These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32096478)

  • 1. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients.
    Martinović KM; Milićević M; Larsen AK; Džodić R; Jurišić V; Konjević G; Vuletić A
    Eur Cytokine Netw; 2019 Dec; 30(4):160-167. PubMed ID: 32096478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.
    Konjević G; Mirjacić Martinović K; Vuletić A; Jović V; Jurisić V; Babović N; Spuzić I
    Clin Exp Metastasis; 2007; 24(1):1-11. PubMed ID: 17295095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
    Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
    Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression.
    Konjevic G; Mirjacic-Martinovic K; Vuletic A; Babovic N
    J BUON; 2012; 17(4):761-9. PubMed ID: 23335538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
    J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
    Fregni G; Messaoudene M; Fourmentraux-Neves E; Mazouz-Dorval S; Chanal J; Maubec E; Marinho E; Scheer-Senyarich I; Cremer I; Avril MF; Caignard A
    PLoS One; 2013; 8(10):e76928. PubMed ID: 24204708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients.
    Vuletić A; Jovanić I; Jurišić V; Milovanović Z; Nikolić S; Spurnić I; Konjević G
    Pathol Oncol Res; 2020 Jan; 26(1):223-231. PubMed ID: 29948616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients.
    Mirjačić Martinović KM; Vuletić AM; Lj Babović N; Džodić RR; Konjević GM; Jurišić VB
    Cytokine; 2017 Aug; 96():30-40. PubMed ID: 28282548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
    Schilling B; Halstead ES; Schuler P; Harasymczuk M; Egan JE; Whiteside TL
    Cancer Immunol Immunother; 2012 Sep; 61(9):1395-405. PubMed ID: 22270713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
    Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
    Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.
    Mirjačić Martinović K; Konjević G; Babović N; Inić M
    J Surg Res; 2011 Dec; 171(2):637-49. PubMed ID: 20828749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
    Lee JC; Lee KM; Kim DW; Heo DS
    J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 decreases MICA expression on melanoma cell surface.
    Serrano AE; Menares-Castillo E; Garrido-Tapia M; Ribeiro CH; Hernández CJ; Mendoza-Naranjo A; Gatica-Andrades M; Valenzuela-Diaz R; Zúñiga R; López MN; Salazar-Onfray F; Aguillón JC; Molina MC
    Immunol Cell Biol; 2011 Mar; 89(3):447-57. PubMed ID: 20714339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible mechanism of impaired NK cytotoxicity in cancer patients: down-regulation of DAP10 by TGF-beta1.
    Lee JC; Lee KM; Ahn YO; Suh B; Heo DS
    Tumori; 2011; 97(3):350-7. PubMed ID: 21789015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.